Actively Recruiting
Biological Collection to Study Pathophysiology and Predictive Factors in Marfan Syndrome and Related Syndromes
Led by University Hospital, Toulouse · Updated on 2026-03-17
300
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting biological samples from patients with Marfan syndrome or related syndromes to support research focused on understanding the disease's effects and progression. Marfan syndrome is a genetic condition that affects the eyes, heart, and skeleton, and is also linked to reduced muscle and fat mass and lower exercise endurance, which can impact quality of life. This observational study aims to gather and store these samples confidentially to help advance future studies on the condition's multisystem effects and to identify factors predicting disease severity. Participants include children aged 3 years and older, as well as adults with Marfan syndrome or related syndromes. During their regular clinic visits, extra blood and urine samples will be collected and stored with consent for research use. This biological collection will enable researchers to quickly access samples as new questions arise in Marfan syndrome research. Participants will be involved during their routine follow-up visits at the Rare Diseases Reference Centre. Samples are collected at enrollment and during these visits to build a comprehensive biological resource. Data confidentiality and patient consent are emphasized. The primary outcome is establishing this biological collection, which will facilitate ongoing and future research into the disease's pathophysiology and progression. The study is sponsored by the University Hospital, Toulouse, and participation spans from enrollment through sample collection at visits.
CONDITIONS
Brief Title
Biological Collection for Marfan and Related Syndromes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged at least 3 years old or adults with Marfan syndrome or related syndromes
- Patients affiliated to or beneficiaries of a social security scheme
- Patients able to receive information on the progress of the study and understand the information form to participate in the study
- Patients or legal representatives who have given their consent to participate in the study (expression of no objection)
You will not qualify if you...
- Patients subject to a legal protection measure (guardianship, curatorship, or safeguard of justice)
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Ongoing during regular check-up visits
Participants who undergo routine care are observed during their regular check-up visits. Extra samples of blood and urine are collected and stored for research purposes with the participant's consent.
Regular check-up visits at the Rare Diseases Reference Centre
Trial Site Locations
Total: 1 location
1
Purpan University Hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
T
Thomas Edouard, MD, PhD
F
Françoise Auriol, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here